| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |